Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Methylphenidate double-blind trial: indication and performing].

L Bliznakova1, S Gerstner, M H Schmidt

  • 1Klinik für Psychiatrie und Psychotherapie des Kindes- und Jugendalters am Zentralinstitut für Seelische Gesundheit, Mannheim, Germany. Lucia.Bliznakova@zi-mannheim.de

Klinische Padiatrie
|January 6, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Molecular prenatal diagnosis in a case of an X-linked dominant chondrodysplasia punctata.

Prenatal diagnosis·2003
Same author

An outbreak of candidemia due to Candida tropicalis in a neonatal intensive care unit.

Mycoses·2003
Same author

Oropharyngeal carriage of Candida species in HIV-infected patients in India.

Mycoses·2003
Same author

[Comorbidity of compulsive disorders in childhood and adolescence].

Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie·2003
Same author

[The Child Environment Survey].

Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany))·2003
Same author

Feeding level and diet quality influence trophic shift of C and N isotopes in Nile tilapia (Oreochromis niloticus (L.)).

Isotopes in environmental and health studies·2003
Same journal

Guidance for the Diagnosis and Treatment of Rare Embryonal and Sarcomatous Brain Tumors-a Report from the Central Nervous System-International Registry for Rare Embryonal and Sarcomatous Tumors German Society of Pediatric Oncology and Hematology Study Group.

Klinische Padiatrie·2026
Same journal

Klinische Padiatrie·2026
Same journal

Association of Fat-free Mass Index and Body Mass Index on Pulmonary Function Tests in Children with Rheumatological Disease-associated Interstitial Lung Disease.

Klinische Padiatrie·2026
Same journal

Synchronous Differentiated Thyroid Carcinoma and Nonthyroid Malignancies in Pediatric Patients: A Registry-based Case Series.

Klinische Padiatrie·2026
Same journal

Intrauterine Ulceration of the Lower Limbs: A Not-so-rare Complication Following Vesicoamniotic Shunting with Somatex.

Klinische Padiatrie·2026
Same journal

Letter to the Editor Regarding the Article "Near-Fatal Asthma Due to Severe Airway Mucus Plugging in a 12-Year-Old Boy".

Klinische Padiatrie·2026
See all related articles

Attention-deficit/hyperactivity disorder (ADHD) is common in children. Psychostimulant therapy, like methylphenidate, is effective for ADHD symptoms. Double-blind trials help verify efficacy and manage side effects.

Area of Science:

  • Child and Adolescent Psychiatry
  • Neurodevelopmental Disorders
  • Pharmacological Treatments

Background:

  • Attention-deficit/hyperactivity disorder (ADHD) is a prevalent psychiatric diagnosis in pediatric populations.
  • Core symptoms include inattention, hyperactivity, and impulsivity, significantly impacting development.
  • Multimodal treatment strategies are employed for managing ADHD.

Observation:

  • Psychostimulant therapy, particularly methylphenidate, demonstrates significant efficacy in treating ADHD.
  • A double-blind trial is warranted when initial methylphenidate efficacy is uncertain.
  • Such trials are also indicated after prolonged psychostimulant use or to assess side effects and compliance.

Findings:

  • Methylphenidate is an effective treatment option for children and adolescents diagnosed with ADHD.

Related Experiment Videos

  • Double-blind trials provide a rigorous method for evaluating treatment effectiveness and patient response.
  • These trials aid in identifying and managing potential adverse effects and enhancing patient adherence.

    • Implications:

    • The findings support the continued use of methylphenidate as a first-line treatment for ADHD.
    • Double-blind trials are crucial for personalized treatment adjustments and ensuring optimal patient outcomes.
    • This approach contributes to improved management of hyperkinetic disorders in young individuals.